Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05720663

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Sponsor: Virginia Commonwealth University

View on ClinicalTrials.gov

Summary

Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions. Decompensation occurs when the liver becomes unable to perform all of its functions adequately. Variceal hemorrhage (bleeding from abnormal vessels in the liver called varices), Ascites (abnormal build-up of fluid in the abdomen), and Encephalopathy (brain confusion as a result of the liver not being able to get rid of toxic substances) are three symptoms of liver decompensation. The purpose of this research study is to investigate better ways to routinely monitor the condition of patients with NASH with compensated cirrhosis and to better pinpoint the development of decompensation in the livers of these patients.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

240

Start Date

2023-04-19

Completion Date

2027-12

Last Updated

2026-04-02

Healthy Volunteers

No

Interventions

OTHER

Standard of care

Participants will receive the standard of care for their condition

Locations (2)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Virginia Commonwealth University

Richmond, Virginia, United States